USA Health Homepage

Navigation

Felicia Wilson

Felicia L. Wilson, M.D.

Pediatric Hematologist/OncologistProfessor of PediatricsSpecialty: Pediatrics, Cancer Care
Refer a Patient
Request an Appointment
Or call to make an appointment1 (251) 410-5437

Board Certifications

  • American Board of Pediatrics (Pediatric Hematology-Oncology)

Education

  • Medical School: Medical University of South Carolina College of Medicine | Charleston, SC
  • Residency: Greenville Hospital System | Greenville, SC
  • Fellowship: Emory University of Medicine | Atlanta, GA

Languages

  • English

Locations

Clinical Trials

Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing SarcomaStatus: open

[752645-5] AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma

Treatment for Pediatric Oncology - Ewing Sarcoma | Bone Cancer

Center for Women's Health
1601 Center Street
Suite 3D
Mobile, AL 36604
Mitchell Cancer Institute
1660 SpringHill Avenue
Mobile, AL 36604
Learn More
251-405-5121
Chemotherapy in Infants with Acute Lymphoblastic LeukemiaStatus: open

17-411 - AALL15P1: A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND#TBD, NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A Gene Rearrangement

Treatment for Pediatric Oncology - Acute Myeloid Leukemia | Leukemia in Infants

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-405-5121
A Study for Patients with Newly Diagnosed Acute Promyelocytic LeukemiaStatus: open

18-042 - AAML1331 A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid A COG Groupwide Phase III Study

Treatment for Acute Myeloid Leukemia | Pediatric Oncology

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-405-5121
17-157 - AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment A Phase III StudyStatus: open

17-157 - AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment A Phase III Study, An Intergroup Study for Participation by COG and the Japanese Study Group for

Treatment for Pediatric Oncology- Hepatoblastoma

Mitchell Cancer Institute
1660 SpringHill Avenue
Mobile, AL 36604
Learn More
251-405-5121
Acute Myeloid Leukemia for PediatricsStatus: open

A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD

Treatment for Pediatric Oncology - Acute Myeloid Leukemia

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-405-5121
This link will open in a new tab or window.